Newsletter | August 14, 2026

08.14.26 -- Why Life Sciences Demand Venture Formation Over Venture Capital

SPONSOR

Join the August 20, 2026 Life Science Leader Live event at 11 AM Eastern by registering for free today. Life Science Leader Chief Editor Ben Comer and experienced panelists will discuss key changes at the FDA, how companies can get the most out of agency interactions, and strategies to lower risks and avoid regulatory surprises. Reserve your spot today.

FEATURED ARTICLE

Why Life Sciences Demand Venture Formation Over Venture Capital

Turning academic discoveries into viable life sciences companies requires more than traditional venture capital. William Garner, M.D., explores why venture formation is key to startup success.

INDUSTRY INSIGHTS

How ReTrans Supports Smarter Literature Surveillance In Pharmacovigilance

Smarter literature surveillance uses automation, expert review, and targeted translation to handle growing volumes, improve signal detection, and reduce manual PV workload.

Hidden Costs Behind Clinical Trial Transportation Issues

Transport issues in trials often stem from fragmented financial workflows. Integrating payments with travel coordination reduces delays and supports reliable visits.

Overcome Common Pre-Filled Syringe Challenges Through Partnership

As demand for pre-filled syringes rises, manufacturers face distinct filling and production challenges. Explore key considerations for overcoming these complexities.

Class 3 Atropisomers: Capture Therapeutic Selectivity In Oncology

Atropisomers are key to modern small molecule drug development. Learn how advanced manufacturing strategies enable the isolation and scalable production of the most effective single isomer.

Connect With Life Science Leader: